ctrl K

AI Score

Unlock

Jasper Therapeutics Inc. (JSPRW)

AI Score

Unlock

0.14

-0.01 (-6.48%)

At close: Feb 28, 2025, 2:55 PM

Jasper Therapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.11M	1.31M	566K	21K	n/a
Gross Profit	n/a	-1.11M	-1.31M	-566K	-21K	n/a
Operating Income	-76.24M	-68.86M	-51.2M	-36.83M	-20.68M	-4.71M
Interest Income	5.06M	5.2M	n/a	n/a	n/a	533.00
Pretax Income	n/a	-66.09M	-37.69M	-30.64M	-31.67M	-4.99M
Net Income	n/a	-64.47M	-24.17M	-23.98M	-31.67M	-4.99M
Selling & General & Admin	20.42M	17.08M	16.57M	11.41M	4.8M	1.09M
Research & Development	55.82M	51.78M	34.63M	25.42M	15.88M	3.62M
Other Expenses	n/a	n/a	586K	-80K	-111K	n/a
Operating Expenses	76.24M	68.86M	51.2M	36.83M	20.68M	4.45M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	68.86M	51.2M	36.83M	20.68M	4.45M
Income Tax	n/a	-1.63M	-13.51M	-6.65M	-38.45K	-277
Shares Outstanding (Basic)	14.58B	10.44M	3.65M	1.14M	277.07K	n/a
Shares Outstanding (Diluted)	14.58B	10.44M	3.65M	1.14M	277.07K	n/a
EPS (Basic)	-4.89	-6.18	-6.63	-21.05	-114.3	n/a
EPS (Diluted)	-4.89	-6.18	-6.63	-21.05	-114.3	n/a
EBITDA	-76.24M	-64.98M	-38.21M	-31.17M	-31.95M	-277K
Depreciation & Amortization	n/a	1.11M	1.31M	566K	21K	4.71M